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EXPERT COMMENTARYThe longstanding, persistent confusion surrounding surgery for atrial
fibrillationJames L. Cox, MDThe surgical treatment of atrial fibrillation (AF) persists in
being a confusing topic, despite the fact that surgeons
have been able to treat this entity successfully for more
than 2 decades. Much of the confusion stems from electro-
physiologic concepts that have arisen from observations
made after catheter ablation, where the interventional elec-
trophysiologists do not know the precise location, length,
depth, or width of their lesions. In addition, the lack of
a physiologically based classification system that is mean-
ingful for patients undergoing interventional therapy for
AF, the indiscriminant use of unproven lesion patterns, the
inability to create transmural and contiguous ablative lesions
reliably, the lack of agreement regarding what constitutes
a surgical failure, and the lack of a standard means of assess-
ing postoperative results have all contributed to the current
state of confusion.CONCOMITANT SURGERY FOR AF
Some surgeons are now questioning the validity of treating
AF surgically in the case of patients who are already entering
the operating room for other cardiac surgery, such as mitral
valve repair. Gammie and associates1 recently reviewed the
Society of Thoracic Surgeons National Cardiac Database
and reported that of 67,389 patients with AF who underwent
surgery for other cardiacproblemsonly 38%underwent a con-
comitant surgical procedure for AF, including 52% of those
undergoing mitral valve surgery, 28% of those undergoing
aortic valve surgery, and 24% of those undergoing isolated
coronary artery bypass grafting (CABG). This disappointing
performancewas seendespite the publication ofmultiple stud-
ies from around theworld confirming the ability of a variety of
concomitant surgical procedures to eliminate AF.2-7 Most
authorities believe that concomitant AF surgery is indicated
not only for patients with AF who are undergoing mitral
valve surgery8-10 but also for patients with AF who are
undergoing CABG or aortic valve surgery.11 Ridding the
patient of AF at the time of mitral valve, aortic valve, or coro-
nary artery surgery has beendocumented to cause no increased
surgical risk12 yet results in multiple benefits relative to leav-
ing these patients in AF postoperatively. The benefits include
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1374 The Journal of Thoracic and Cardiovascular Surmorbidity,14 lower incidences of thromboembolic events
and valve-related complications,15,16 improvement in the
commonly associated problem of tricuspid regurgitation,17,18
and improved patient survival.16,19 Indeed, the surgical
literature of the past decade leaves no doubt that the
concomitant surgical treatment of AF associated with other
cardiac surgery should increase in the future.
The current lack of aggressiveness in treating AF with
concomitant surgical procedures has other consequences.
For example, it is uncommon for surgeons to perform
stand-alone operations for AF. The usual explanation for
this is, ‘‘My referring cardiologist won’t refer these
patients.’’ There are likely several reasons for the lack of re-
ferrals, but 2 stand out: (1) stand-alone surgical procedures
are not referred because many surgeons do not even rou-
tinely treat AF with a concomitant cardiac surgical proce-
dure, and (2) most contemporary surgical techniques are
left-sided procedures, and although they may be fairly effec-
tive as concomitant procedures for AF, they are not nearly so
effective when applied as stand-alone procedures for AF.
Indeed, the stand-alone surgical results with left-sided
procedures may be no better than those attained by catheter
ablation. Because these procedures are obviously more inva-
sive, why should cardiologists be expected to refer their pa-
tients with AF to surgeons if they cannot expect to see
a significant improvement in outcome?
PAROXYSMAL AND CHRONIC AF
The term atrial fibrillation is a clinical diagnosis that is
based on the findings of an irregular P wave and an irregu-
larly irregular QRS complex on the standard limb-lead elec-
trocardiogram. The clinical diagnosis of AF reveals little,
however, about the underlying electrophysiologic events
that are actually occurring in the atria. For example, the elec-
trocardiographic findings of AF can be caused by a single
unstable macro-reentrant circuit in either atrium, by 2 simul-
taneous macro-reentrant circuits in a single atrium, by a sin-
gle macro-reentrant circuit in each atrium, or by as many as 6
simultaneous macro-reentrant circuits (Figure 1).20-23 AF is
either paroxysmal or nonparoxysmal. Individual episodes of
paroxysmal AF (PAF) depend on focal atrial triggers for
their induction; once induced, however, the individual
episodes are sustained by self-perpetuating macro-reentrant
circuits in the atrium until they spontaneously terminate.
Haı¨ssaguerre and associates24 and others25 have demon-
strated that the focal triggers that induce PAF are in and
around the pulmonary vein (PV) orifices in approximately
90% of patients.gery c June 2010
FIGURE 1. Atrial fibrillation. This posterior view of the heart is also shown in Figures 4, 5, 6, 8, and 9. These are some of the combinations of macro-
reentrant circuits in the atria that can cause the electrocardiographic findings of atrial fibrillation. Note that in most cases the macro-reentrant circuits are
smaller in the left atrium than in the right atrium (B, C). Also, most ‘‘normal’’ right atria are capable of harboring only 1 much larger macro-reentrant circuit,
the so-called ‘‘flutter wave,’’ which traverses the cavotricuspid isthmus (A, C). In patients with primary atrial fibrillation, however, which arises de novo in
a grossly normal heart, there may be 2 or more macro-reentrant circuits in the right atrium (D).
Cox Expert CommentaryBy definition, all AF that does not occur sporadically is
nonparoxysmal AF, which includes the subcategories of per-
sistent, longstanding persistent, permanent, chronic, contin-
uous, or any other arbitrary designation that refers to AF that
is not paroxysmal (Figure 2). Because the term nonparoxys-
mal AF is cumbersome and unfamiliar to most surgeons,
however, the remainder of this discussion will refer to all
nonparoxysmal AF as chronic AF (CAF).
Whereas PAF depends on atrial triggers for its induction,
CAF requires no such triggers because it does not need to be
repeatedly induced. CAF occurs because the self-
perpetuating macro-reentrant circuits (drivers) in the atria
that spontaneously terminate in patients with PAF no longer
terminate; thus, the AF becomes nonparoxysmal or chronic.
These macro-reentrant drivers can occur virtually anywhere
in either atrium and are usually at least 5 cm in diameter, not
1 to 2 cm in diameter or smaller as implied in such prominent
publications as the Heart Rhythm Society/European Heart
Rhythm Association/European Cardiac Arrhythmia Society
Expert Consensus Statement.26 The presence of these self-
perpetuating macro-reentrant drivers, and the fact that theyThe Journal of Thoracic and Carare physically large rather than focal, is the reason that PV
isolation alone will not cure CAF and why it is necessary
to add strategically placed linear lesions in these patients.
PRIMARYAND SECONDARYAF
Arrhythmia surgeons deal almost exclusively with AF
that arises secondary to some type of left heart problem, usu-
ally mitral valve disease but also aortic valve disease, ische-
mic heart disease, or left heart failure. This AF is frequently
referred to as concomitant AF, but it is more accurate to think
of it as secondary AF that is treated with a concomitant sur-
gical procedure. A few arrhythmia surgeons also treat pa-
tients with AF that is not associated with another cardiac
problem severe enough to warrant surgery. This is com-
monly referred to as stand-alone AF, but it is more accurate
to think of it as primary AF that is treated with a stand-alone
surgical procedure. Before performing concomitant surgery
for AF, all patients should be classified as having either sec-
ondary PAF or secondary CAF (Figure 3). Before perform-
ing stand-alone surgery for AF, all patients should be
classified as having either primary PAF or primary CAF.diovascular Surgery c Volume 139, Number 6 1375
FIGURE 2. The American Heart Association/American College of Cardiology/European Cardiology Society classification system is extremely helpful to
physicians who treat atrial fibrillation with drugs. It is of little or no value to interventional cardiologists or surgeons who treat atrial fibrillation by interven-
tional methods, however, because it is not based on any underlying electrophysiologic differences between various arbitrary categories, nor does it help in
determining appropriate interventional procedure to be performed. There are only 2 underlying electrophysiologic mechanisms in atrial fibrillation that
can be altered physically by catheter or surgical intervention: focal triggers that induce individual episodes of atrial fibrillation and macro-reentrant drivers
that sustain atrial fibrillation once it has been induced. Interventional classification in this figure is based on these 2 electrophysiologic properties of atrial
fibrillation that not only differentiate paroxysmal atrial fibrillation from nonparoxysmal atrial fibrillation but also dictate appropriate interventional approach
to each. Because nonparoxysmal atrial fibrillation is cumbersome and unfamiliar to most interventionalists and surgeons, it has been largely replaced in lit-
erature with more traditional and familiar chronic atrial fibrillation. When applied as a descriptor of atrial fibrillation, chronic does not indicate duration of
atrial fibrillation but rather its persistence and thus includes all forms of atrial fibrillation that are not paroxysmal. Thus for purposes of interventional therapy,
not only is it more convenient to think of all atrial fibrillation as being either paroxysmal or chronic but it is also more accurate from both mechanistic and
therapeutic standpoints.AHA,American Heart Association;ACC,American College of Cardiology; ECS, European Cardiology Society; AF, atrial fibrillation.
Expert Commentary CoxPrimary and Secondary PAF
Both primary and secondary PAF are caused by focal trig-
gers that are usually located in or near the PV orifices, and
both therefore can be treated successfully with PV isolation.
Surgeons are rarely referred patients with primary PAF,
because satisfactory results can be attained by catheter abla-
tion in these cases. Because secondary PAF occurs
frequently in patients undergoing other cardiac surgery,
however, concomitant surgical PV isolation is a commonly
used procedure.27 Although this would seem to be appropri-
ate for all patients with secondary PAF, PV isolation alone
can be quite arrhythmogenic, especially in patients with en-
larged or diseased left atria, in which setting atypical left
atrial flutter (Figure 4) is a frequent postoperative occur-
rence. Atypical left atrial flutter is characterized by a long re-
entrant circuit formed around the PV-isolating lesions in
which the electrical impulse travels along the left atrial isth-
mus between the inferior PVs and the mitral annulus,
through the atrial septum, around the anterior left atrium
above the mitral annulus, and then in the lateral left atrium
beneath the orifice of the left atrial appendage. If a patient
is undergoing surgery for mitral valve disease in which the
left atrium is already opened it is therefore advisable, even
for secondary PAF, to go ahead with a complete left atrial
maze III lesion pattern, which usually adds less than 15 min-1376 The Journal of Thoracic and Cardiovascular Surutes to the operative procedure. The right atrial maze III le-
sions can then be added during the rewarming phase without
extending the operative time. In patients with secondary
PAF who are undergoing aortic valve surgery or CABG,
however, where a left atriotomy is not otherwise required,
it is reasonable to perform a simple epicardial PV isolation.
Primary and Secondary CAF
Although both primary and secondary CAF depend on the
presence of macro-reentrant drivers for their maintenance,
there are critical electrophysiologic differences between
the two that can doom a surgeon’s stand-alone practice for
AF if they are ignored. The critical difference relates to the
number of macro-reentrant circuits that can occur in the right
atrium under various clinical conditions. These differences
explain why satisfactory results can often be attained in pa-
tients undergoing concomitant surgery28,29 but not stand-
alone surgery, despite identical lesion pattern and energy
source.30 The durations of the local refractory periods in
atrial tissue determine the physical size of local macro-
reentrant circuits.31 Areas of the atrium with shorter refrac-
tory periods can harbor smaller macro-reentrant circuits,
whereas areas with longer refractory periods can harbor
only larger macro-reentrant circuits. The refractory periods
in the left atrium are normally shorter than those in the rightgery c June 2010
FIGURE 4. Atypical left atrial flutter. This is an iatrogenic arrhythmia that
can occur after pulmonary vein isolation by any of the techniques usually
used, regardless of the energy source used. The electrical impulse travels
around the reentrant circuit diagrammed approximately 240 times per min-
ute. After being blocked 2:1 in the atrioventricular node, atypical left atrial
flutter causes a regular ventricular response of approximately 120 beats/min
and is a particularly stable and recalcitrant arrhythmia.
FIGURE 3. According to the interventional classification described in
Figure 2, all patientswith atrial fibrillation have either paroxysmal atrial fibril-
lation or chronic atrial fibrillation. In addition, all patients with atrial fibrilla-
tion can be divided into those with primary and secondary atrial fibrillation.
Primary atrial fibrillation is defined as atrial fibrillation that occurs in patients
who have no associated gross cardiac diseases or abnormalities that are severe
enough to warrant surgical correction. Thus, any surgical procedure for pri-
mary atrial fibrillation would be performed as a stand-alone procedure; that
is, the patient is having cardiac surgery solely to treat atrial fibrillation. Sec-
ondary atrial fibrillation is defined as atrial fibrillation resulting fromother car-
diac diseases or abnormalities that are severe enough to warrant cardiac
surgery. Thus, any surgical procedure for secondary atrial fibrillation would
be added to the main surgical procedure as an adjunctive or concomitant pro-
cedure for atrial fibrillation.All patientswho are to undergo surgical treatment
for atrial fibrillation should be categorized into 1 of these 4 distinctive groups,
not only for purposes of determining optimal surgical therapy but also to re-
port accurate andmeaningful surgical results.PAF, Paroxysmal atrial fibrilla-
tion; CAF, chronic atrial fibrillation.
Cox Expert Commentaryatrium,32 so macro-reentrant circuits that form in the left
atrium are usually smaller than those in the right atrium
(Figure 1,C). In fact, because of its relatively long refractory
periods, the normal right atrium is capable of harboring only
a single large macro-reentrant circuit, the classic atrial ‘‘flut-
ter wave’’ that traverses the cavotricuspid isthmus.32,33 Thus
to choose the appropriate surgical approach for each patient,
one must take into account not only the type of AF present
but also the clinical statuses of both the right and left atria.
Secondary CAFwith a normal right atrium. Because the
right atrium may not be affected by left heart problems, such
as mitral or aortic valve disease, ischemic heart disease, or
left heart failure, the normal right atrium in these patients
is still capable of supporting only a single macro-reentrant
circuit, the right atrial flutter wave (Figure 5). Thus the
macro-reentrant drivers responsible for the secondary CAF
in such patients reside predominantly in the left atrium,
and concomitant AF surgical procedures confined to the
left atrium therefore can have a relatively high success rate
in such patients. After strictly left-sided concomitant proce-
dures, however, approximately 10% of these patients will
have postoperative atrial flutter originating from the right
atrium.34 Some surgeons therefore add a right atrial ‘‘flutterThe Journal of Thoracic and Carlesion’’ to their concomitant left-sided surgical procedures.
Others choose to ignore the possibility of postoperative atrial
flutter from the right atrium and let their cardiologists treat it
with catheter ablation should it occur. Either approach is rea-
sonable.
Secondary CAF with an abnormal right atrium. If the
right atrium is enlarged or stretched as a result of the left
heart problem, it may become large enough to support two
simultaneous macro-reentrant circuits (Figure 6). In that
case, concomitant AF procedures confined to the left atrium
will fail because the postoperative persistence of multiple
macro-reentrant circuits in the enlarged right atrium can still
cause AF postoperatively. Thus although concomitant left-
sided AF procedures are generally fairly effective for sec-
ondary CAF, if there is any hint of right atrial involvement,
the patient should have the full set of maze III lesions applied
in the right atrium as well as in the left atrium. This is per-
haps the most frequent reason for recurrent AF after strictly
left-sided concomitant AF procedures for the treatment of
CAF secondary to mitral valve disease. Moreover, the addi-
tion of a right atrial flutter lesion would have no effect what-
soever on the occurrence of postoperative AF in these
patients, because that lesion is only effective for atrial flutter
coming from the right atrium.
Because it is not always possible to know whether the
right atrium is affected by the left heart problems in these pa-
tients, even when looking directly at the right atrium duringdiovascular Surgery c Volume 139, Number 6 1377
FIGURE 5. Concomitant left-sided surgery for secondary chronic atrial fibrillation with an enlarged left atrium (LA) and a normal right atrium (RA). Left
panel, Patients with chronic atrial fibrillation secondary to mitral valve disease usually have an enlarged left atrium, but the right atriummay be normal. In such
cases, macro-reentrant drivers responsible for the chronic atrial fibrillation are invariably located in the left atrium, explaining why concomitant surgical pro-
cedures confined to the left atrium are quite successful in this group of patients. Because the right atrium is normal, it can harbor only 1 large macro-reentrant
circuit, the so-called ‘‘flutter wave,’’ which usually traverses the cavotricuspid isthmus. Right panel, If concomitant surgical procedure is confined to the left
atrium and the right atrium is ignored, classic atrial flutter from persistent right atrial flutter wave will occur postoperatively in about 10% of patients. A right
atrial ‘‘flutter lesion’’ placed across the cavotricuspid isthmus at surgery will preclude this postoperative atrial flutter but it requires opening the right atrium.
Thus, most surgeons ignore the right atrium entirely and have their electrophysiologist treat any postoperative right atrial flutter by catheter ablation.
Expert Commentary Coxsurgery, and because it takes only about 10 minutes and no
additional pump time to perform the right atrial lesions of the
maze III lesion set, it seems prudent to add the right-sided
lesions in all patients undergoing combined mitral valve
and AF surgery. This is especially true in view of the fact
that, unlike the right atrial flutter lesion, the right atrial
maze III lesions prevent both AF and atrial flutter that might
arise postoperatively in the right atrium. If the associated
surgical procedure is aortic valve replacement or CABG,
the best results for secondary CAF would be attained by per-
forming a full biatrial maze III lesion pattern. Because that
set currently requires a left atriotomy for proper perfor-
mance, however, the decision of whether to add the biatrial
procedure or perform some other lesser procedure is at the
surgeon’s discretion.
A word of caution is warranted here. The right atrial cav-
otricuspid flutter lesion ablates right atrial flutter but not
right AF, whereas the right atrial maze lesions ablate both.
It is never acceptable, however, to perform both the right
atrial cavotricuspid flutter lesion and the right atrial maze le-
sions in the same patient. This combination of lesions actu-
ally isolates the lower third of the right atrial free wall
(Figure 7), and that is the site of origin of the normal sinus
rhythm impulse during heart rates less than 60 beats/
min.35 Thus if the heart rate normally drops below that level,
say when a patient is asleep, there may be no primary mech-1378 The Journal of Thoracic and Cardiovascular Suranism for generating a sinus rhythm if the lower third of the
right atrium has inadvertently been isolated.
Primary CAF. I was wrong for several years in believing
that a properly performed stand-alone left atrial maze III
lesion set without the right atrial maze III lesions would
cure primary CAF at the same rate that it cured secondary
CAF when performed as a concomitant procedure.28,36,37
Clinical experience eventually demonstrated that after
a stand-alone left-sided procedure for primary CAF, the re-
currence rate of AF could be 50% or more.30 Clearly, AF
surgical procedures that are confined to the left atrium fail
much more often when they are used as stand-alone proce-
dures to treat primary CAF than when they are used as
concomitant procedures to treat secondary CAF. This
dramatic difference in surgical results was the observation
that established unequivocally that there was a critical differ-
ence in the electrophysiologic mechanisms underlying sec-
ondary CAF and primary CAF.
It is important to recognize that primary CAF arises de
novo in an otherwise grossly normal heart, or at least in a heart
that has no obvious clinical cause for the AF (mitral, aortic, or
ischemic disease). Why? One reason is that in patients with
primary CAF, the right atrium may have abnormally short re-
fractory periods, meaning that their corresponding right atrial
macro-reentrant circuits can be smaller than normal.38 Thus,gery c June 2010
FIGURE 6. Concomitant left-sided surgery for secondary chronic atrial fibrillation in which both atria are enlarged. Left panel, In many patients with chronic
atrial fibrillation secondary to mitral valve disease, the right atrium (RA) may be enlarged enough to support 2 or more large macro-reentrant circuits, even
though the long refractory periods are unchanged from normal. In this case, a concomitant surgical procedure confined to the left atrium (LA, right panel)may
ablate the culprit macro-reentrant drivers in the left atrium but leave behind the 2 potential macro-reentrant circuits in the right atrium. Should these right atrial
macro-reentrant circuits then become active, they can serve as drivers for atrial fibrillation after surgery. The addition of a right atrial ‘‘flutter lesion’’ will have
no effect on the recurrence of postoperative atrial fibrillation in such patients. For this reason, the right atrial lesions of the maze procedure should be added in
all patients with chronic atrial fibrillation that is secondary to mitral valve disease unless the surgeon can be absolutely certain that the right atrium is com-
pletely normal (see Figure 5), which is very difficult without a preoperative electrophysiologic study.
Cox Expert Commentaryunlike the situation in the normal right atrium, multiple
macro-reentrant drivers can reside simultaneously within the
normal-appearing right atrium in patients with primary CAF
(Figure 8). Clearly, a stand-alone AF surgical procedure con-
fined to the left atrium,with orwithout addition of a right atrial
flutter lesion, would fail in such patients because of the post-
operative persistence of the multiple macro-reentrant drivers
in the right atrium. Indeed, a sure way to preclude the devel-
opment of a viable clinical practice treating primary CAFwith
stand-alone surgical procedures is to use procedures that are
confined to the left atrium!
IMPORTANCE OF LESION PATTERNS
In 1998, Haı¨ssaguerre and associates24 published their
seminal article demonstrating for the first time that most epi-
sodes ofAFare inducedby focal triggers in and around thePV
orifices. This article led to an explosion of industry involve-
ment in the field, with the introduction ofmultiple new energy
sources incorporated into surgical devices that were designed
primarily for encircling the PVs.28,39-42 This simultaneous
introduction of 2 variables into the surgical treatment of AF,
new energy sources and new lesion patterns, directly
violated a cardinal rule of scientific investigation, which
demands that all variables in an experiment be controlled
save the one being evaluated. The violation of this simple
but basic scientific principle preordained the massive
confusion that we now face in trying to interpret the reasonThe Journal of Thoracic and Carfor surgical failures. Are they due to the inadequacy of the
energy source or to inappropriate lesion sets? With two
variables having been introduced simultaneously some 10
to 12 years ago, it is impossible to answer that question
definitively. The common practice is to incriminate the
energy source rather than the lesion pattern as the cause of
AF surgical failures,39,43,44 a practice that I believe is
a direct result of the influence exerted by industry on the
mindset of surgeons involved in treating AF. Industry is
less attuned to the importance of lesion patterns than it is to
the differences in energy sources because there is no profit
from lesion patterns, only from energy sources. Thus
incomplete lesion patterns are rarely incriminated as the
reason for suboptimal surgical results.
Another reason that the importance of lesion patterns has
been deemphasized is that during the past decade, the pri-
mary objective of most new surgical procedures for AF
has been to make them as minimally invasive as possible.
Consequently, the lesion pattern has been relegated to a sec-
ondary role in surgical procedures, being largely dictated by
the limitations of surgical exposure and the previously se-
lected energy source.39,43,45 It is now clear, however, that
if the primary end point is an optimal outcome, the future
design of AF surgical procedures must start with the
premise that whatever surgical exposure or energy source
is used, the lesion pattern should be consistent and involve
both atria. Barnett and Ad’s extensive meta-analysis of thediovascular Surgery c Volume 139, Number 6 1379
FIGURE 7. Inadvertent isolation of the lower right atrium. The combination of the superior vena cava (SVC) to inferior vena cava (IVC) lesion and the T
lesion of the maze procedure normally results in the lower one third of the right atrium being activated via the cavotricuspid isthmus after surgery. Therefore,
adding the flutter lesion across the cavotricuspid isthmus in combination with those 2 lesions of the maze procedure electrically isolates the lower one third of
the atrium. Thus, the flutter lesion should never be added in combination with the right atrial maze lesions.
Expert Commentary Coxsurgical literature covering 69 studies and 5885 surgical pa-
tients46 and Rostock and colleagues’ catheter ablation study
from Hamburg47 both resulted in the same conclusion. Fur-
thermore, after a thoughtful in-depth analysis of the logic be-
hind different lesion patterns, Gillinov48 agreed that biatrial
lesion sets were necessary for optimal surgical results and
stated that the biatrial maze III lesion pattern still attained
the best outcomes. If we accept that optimal surgical results
depend on the creation of completely transmural and contig-
uous bilateral atrial lesions in the maze III pattern, surgeons
can start from that established reference point and then ad-
dress the issue of how to place that lesion set in or on the
heart with the least possible degree of surgical invasiveness.
These studies reinforce the historical message that the
cut-and-sew maze III procedure has been successful not
only because all of the surgical incisions are contiguous
and transmural but also because they are placed in the correct
pattern. Despite complete transmurality of all of the inci-
sions, had they been placed in some other arbitrary pattern,
such as so-called ‘‘left-sided mazes’’ or simple PV isolation,
the knife and scissors would have had just as high a failure
rate as most procedures with the newer ablative energy sour-
ces. The logical corollary is that any ablative energy source
that is applied in a maze III lesion pattern in which every le-
sion is both transmural and contiguous will cure AF at the
same rate as the old cut-and-sew surgical technique. Because1380 The Journal of Thoracic and Cardiovascular Sursurgical failures are almost invariably attributed to the
energy source rather than to the lesion pattern, a potentially
excellent energy source could be unjustifiably discarded as
ineffective simply because it was used to create the wrong
lesion pattern. This may well have been the case with micro-
wave and laser energy, both of which were withdrawn from
the market despite the fact that few if any complete maze III
lesion patterns were ever created with either energy source.
Thus how sure can one be that the energy sources were the
problem? On the contrary, if one performs a complete and
accurate maze III lesion pattern using any of the available
energy sources and it fails, one can be certain that either
the energy source was inadequate (not all lesions were trans-
mural), a surgical error was made in applying that energy
source, or both.
Patients, industry, cardiologists, and many surgeons are
accustomed to hearing such comments as, ‘‘The patient
had a maze procedure for AF, but it failed.’’ Of course
this could be true, but commonly the patient in question
did not undergo a true maze procedure at all, but rather
one of the ‘‘modified’’ procedures. Some of these proce-
dures actually have the term maze as a part of their common
titles, such as theWolf MiniMaze procedure,39,49 which is in
reality only a simple PV isolation plus closure of the left
atrial appendage. Although the Wolf MiniMaze is an
innovative way to isolate the PVs with minimally invasivegery c June 2010
FIGURE 8. Stand-alone left-sided surgery for primary chronic atrial fibrillation with normal left atrium (LA) and normal right atrium (RA). The right atrium
can normally support only 1 large macro-reentrant circuit because of its long refractory periods; however, in patients with primary chronic atrial fibrillation
that arises de novo in a grossly normal heart, the right atrium may have shorter refractory periods and therefore can harbor smaller macro-reentrant circuits.
This allows a normal-appearing right atrium to support 2 macro-reentrant circuits, which can be just as important in driving atrial fibrillation as those in the left
atrium (see Figure 1, D). Thus stand-alone surgical procedures that are confined to the left atrium in patients with primary chronic atrial fibrillation often fail
because these right atrial drivers persist postoperatively. Adding a right atrial ‘‘flutter lesion’’ has no effect whatsoever on the recurrence of postoperative atrial
fibrillation in these patients. It is this unique electrophysiologic difference between right atrial electrophysiology in primary and secondary chronic atrial fi-
brillation that results in strictly left-sided procedures being highly successful as concomitant procedures for secondary chronic atrial fibrillation but dismal
failures as stand-alone procedures for primary chronic atrial fibrillation.
Cox Expert Commentarysurgical techniques, its electrophysiologic mechanism of
action in treating AF is not different from any other PV
isolation procedure. Thus it offers no advantage relative to
catheter ablation, especially in patients with CAF.
The Ex-Maze procedure is performed with radiofre-
quency energy, and although the lesion pattern is closer in
principle to the maze lesion set than to the Wolf MiniMaze
set, the Ex-Maze still falls short of creating a true maze of
lesions in the atria. Therefore the possibility of recurrent
atrial macro-reentry (AF or atrial flutter) is not precluded be-
cause there is no atrial line to the mitral annulus, there is no
coronary sinus lesion, and the arbitrary right atrial lesions are
unproven.50 Nevertheless, the minimally invasive approach
used by Kiser in performing the Ex-Maze procedure repre-
sents a significant innovation in surgical technique that
may eventually prove to be useful in performing a truly
endoscopic epicardial maze procedure. Kiser has now aban-
doned the original Ex-Maze procedure in favor of the so-
called ‘‘convergent procedure,’’ which is a hybrid operation
that includes epicardial lesions placed by the surgeon and
endocardial lesions placed by an interventional cardiologist
(Kiser AC, unreferenced personal communication, Oct
2009).
Similarly, the recent claim that the ‘‘Dallas lesion set’’ is
‘‘electrophysiologically equivalent to all the left atrialThe Journal of Thoracic and Carlesions of the Cox maze III’’ is incorrect, nor is it accurate
to state that ‘‘it has been proven that the right-sided lesions
of the maze procedure are not necessary.’’51 Theoretically,
the Dallas procedure (Figure 9) should be just as effective
as the maze III procedure in preventing postoperative atyp-
ical left atrial flutter (Figure 4) if the anterior lesion across
the dome of the left atrium is indeed transmural and reaches
the mitral annulus as claimed. It does not matter whether the
reentrant circuit responsible for atypical left atrial flutter is
interrupted posteriorly, as in the maze procedure, or anteri-
orly, as in the Dallas procedure; however, that is where
most similarities between the 2 procedures end.
The anterior incision across the dome of the left atrium
down to the left fibrous trigone in the Dallas procedure di-
vides Bachmann’s bundle, which is the finger-sized muscle
bundle that connects the top of the right atrium to the top of
the left atrium. This is the pathway that allows the left and
right atria to become activated at virtually the same instant
(within 40 ms), even though the impulse is generated in
the right atrium alone. This in turn assures that atrioventric-
ular synchrony is maintained in both sides of the heart.
A similar lesion that divided Bachmann’s bundle was in-
cluded in the original maze I procedure,52 and it was a major
reason that we modified the maze I procedure to the maze II
and finally the maze III procedure.53,54 The combination ofdiovascular Surgery c Volume 139, Number 6 1381
FIGURE 9. The Dallas procedure. Conduction from the sinus node in the top of the right atrium to the top of the left atrium normally takes only 40 mil-
liseconds because of the rapidity of impulse propagation across Bachmann’s bundle. This rapid impulse conduction across Bachmann’s bundle is possible
because its fibers are oriented parallel to the direction of impulse propagation. This allows virtually simultaneous activation and contraction of the right and left
atria. In the Dallas procedure, the ‘‘mitral line’’ and coronary sinus lesions of the maze procedure are deleted and a new lesion is placed anteriorly across the
dome of the left atrium. This lesion blocks all conduction from the right to left atrium across Bachmann’s bundle and forces the right atrial sinus impulse to
activate the left atrium via a posterior route across the crista terminalis and the left atrial isthmus between the inferior pulmonary veins and the posterior mitral
annulus. The fibers of crista terminalis are oriented perpendicular to the direction of impulse propagation and, therefore, the speed of conduction is greatly
slowed as the impulse traverses the crista terminalis. This results in a delay in the activation of the left atrium that, if severe enough, can result in the left atrium
actually being activated almost simultaneously with the left ventricle. If that occurs, as it did in the original maze I procedure, all left atrial transport function is
essentially lost because the left atrium will be contracting against the closed mitral valve.
Expert Commentary Coxdividing Bachmann’s bundle and encircling the PVs with
a ‘‘box lesion’’ can cause a severe intra-atrial conduction de-
lay in some patients, which results in the left atrium and the
left ventricle beating at the same time, effectively eliminat-
ing all left atrial transport function. In addition, the rationale
behind the Dallas procedure, that it is a technically easier
way to prevent postoperative atypical left atrial flutter, ig-
nores the fact that atypical left atrial flutter is not the only
failure mode in patients who have no mitral line or coronary
sinus lesion placed beneath the inferior PVs. In fact, a com-
mon failure mode in such patients is late AF from the pres-
ence of macro-reentrant drivers in the left atrial isthmus near
the coronary sinus (Figure 10).55 The left atrial isthmus, in-
cluding the coronary sinus, has been shown repeatedly to be
a very arrhythmogenic region of the atrium,56-61 and one
ignores the importance of these anatomic structures in
initiating and sustaining AF at one’s own risk. Finally, the
Dallas lesion set currently includes no right atrial lesions
at all,51 a fact that will cause many unnecessary failures in-
dependent of those that will arise from deletion of the lines
of conduction block across the left atrial isthmus/coronary
sinus.
Having enumerated these many differences between the
Dallas procedure and the maze procedure, it should be men-
tioned that the potential intra-atrial conduction block with
the Dallas procedure may not be as severe as it was with
the maze I procedure, because conduction across the left
atrial isthmus was complete in the maze I procedure because1382 The Journal of Thoracic and Cardiovascular Surof the ‘‘mitral line’’ and coronary sinus lesions. Deletion of
those lesions in the Dallas procedure allows the impulse to
travel from the right atrium to the left atrium across this isth-
mus. The impulse will not travel as quickly across the isth-
mus as it normally would across Bachmann’s bundle,
however, because the myocardial fibers in Bachmann’s
bundle are oriented parallel to (in the direction of) impulse
propagation and therefore promote extremely rapid conduc-
tion. After the creation of conduction block through
Bachmann’s bundle with the Dallas procedure, the sinus
impulse must traverse the crista terminalis posteriorly to en-
ter the left atrium, and those fibers are oriented perpendicu-
lar to the direction of impulse conduction, which greatly
slows conduction of the sinus impulse from the right atrium
to the left atrium (Figure 9).62 Although this example of
‘‘anisotropy of conduction’’ will not likely result in com-
plete conduction block between the right and left atria pos-
teriorly, it may well delay conduction from the right atrium
to the left atrium enough to cause the left atrium and the left
ventricle to beat simultaneously as they too often did after
the original maze I procedure. If this intra-atrial conduction
delay proves to be insignificant, if recurrent AF from resid-
ual macro-reentrant drivers in the left atrial isthmus does not
prove to be a problem, and if surgeons add the right-sided
maze III lesions, the left atrial lesion set of the Dallas pro-
cedure holds promise as a viable alternative to the left atrial
lesion set of the maze procedure. A separate critical concern
with Dallas approach, however, relates to the questionablegery c June 2010
FIGURE 10. Atrial fibrillation. This is the intraoperative activation map of
the first patient ever mapped with a multipoint (156 epicardial bipolar elec-
trodes) computerized mapping system while in atrial fibrillation. Note the
macro-reentrant circuit in the left atrial isthmus between the inferior pulmo-
nary veins (PV) and the mitral annulus. Because the Dallas procedure de-
letes the ‘‘mitral line’’ and coronary sinus lesions of the maze procedure,
the Dallas procedure is vulnerable to such macro-reentrant drivers causing
recurrent atrial fibrillation postoperatively. Indeed, occasional failure to
block conduction across the left atrial isthmus was the Achilles’ heel of
the maze procedure, as all 7 early maze procedure failures were shown to
have postoperative conduction across the left atrial isthmus. Some recur-
rences took the form of atypical left atrial flutter but others were due to atrial
fibrillation resulting frommacro-reentrant circuit in the left atrial isthmus, as
shown in this figure. The Dallas procedure should theoretically be as effec-
tive in preventing atypical left atrial flutter as the maze procedure, but the
Dallas procedure remains susceptible to recurrent atrial fibrillation due to
the type of persistent macro-reentry in the left atrial isthmus shown in this
figure. Posterior view with anterior atria ‘‘flipped up’’ for exposure.M,Mi-
tral valve; T, tricuspid valve; SVC, superior vena cava; IVC, inferior vena
cava.
Cox Expert Commentaryability of any currently available energy source to create re-
liable permanent transmural lesions in the atrium from the
epicardial surface in a beating heart. Thus the unpredictabil-
ity of an epicardial energy source coupled with a new un-
proven lesion pattern portends a significant failure rate in
the future, again with no ability to tell whether the failures
are due to the energy source or to the lesion pattern.DEFINITIONS OF SUCCESS AND FAILURE
‘‘Freedom from AF’’ is a legitimate end point only if it
means the same thing to all investigators. After a blanking
period of 3 to 6 months, all cases of postoperative AF, post-
operative atypical left atrial flutter, and postoperative classic
right atrial flutter should be classified as failures. Clinically,
patients often tolerate AF better than they tolerate atrial flut-
ter,63 so if a surgical procedure successfully ablates AF but
leaves the patient with atrial flutter, the procedure cannot
honestly be called a success, or at least it won’t be consid-The Journal of Thoracic and Carered so by the patient! Thus if only AF is reported as a failure
of a surgical procedure, the alleged success rates are not only
inflated but also misleading and inaccurate.
The methods by which these postoperative recurrences
are to be detected remain a source of some controversy. It
has been suggested that the ‘‘harder one looks’’ for AF re-
currences, the more recurrences one will find. For example,
the apparent success rates in a given series of patients under-
going surgery for AF are best if the only end point is absence
of AF on a standard electrocardiogram, slightly worse if the
patients are subjected to 24-hour Holter monitoring, and
worst if they are continuously monitored for 1 week.64,65
Although this may be demonstrable in some series,
I believe that there are 2 reasons that such studies are not
as important as they might seem. First, if one does the
correct operation to begin with, the disparity between the
different monitoring methods will virtually disappear,
because the AF will have been successfully ablated and no
amount of monitoring will change that fact. In other
words, major differences among these 3 methods of
follow-up occur primarily in series in which the original op-
eration was inadequate. Second, the 1-week monitoring is
usually done with a system that is incapable of differentiat-
ing between irregular premature atrial beats and runs of AF.
Because we know that at least 10% of the ‘‘triggers’’ that
induce AF lie outside the isolated PV cuff after surgery,
and because no surgical procedure ablates these, we should
expect roughly 10% of patients to have occasional episodes
during which their nonisolated ‘‘triggers’’ cause premature
atrial beats, events that could be erroneously interpreted by
long-term monitoring to be AF. Because 24-hour Holter
monitoring can distinguish between clusters of irregular pre-
mature atrial beats and AF, the apparent ‘‘incidence of AF’’
would naturally be lower with the Holter monitor than with
the nondiscriminating long-term monitoring systems. Nev-
ertheless, because of the popular notion that these different
end points affect the surgical results, one might question
the validity of the success rates reported by Prasad and col-
leagues66 for our original cut-and-sew maze patients from St
Louis, the suggestion being that those results were artifi-
cially inflated because of the lack of prolonged monitoring
at term. On the contrary, rather than performing such a pas-
sive assessment as ‘‘monitoring’’ of our original maze pa-
tients, the first 69 patients were all brought back to Barnes
Hospital 6 months postoperatively for complete formal elec-
trophysiologic studies. All patients had been off all antiar-
rhythmic medication for at least 3 months, and every
patient was subjected to the full programmed electrical stim-
ulation and burst pacing protocols that they had received
preoperatively. AF could not be induced in a single patient.
The patients were then started on a continuous intravenous
isoproterenol drip, and the programmed electrical stimula-
tion and burst pacing protocols were repeated. Again, not
a single instance of AF could be induced. Importantly, therediovascular Surgery c Volume 139, Number 6 1383
Expert Commentary Coxwere no differences in the 6-month, 5-year, 8.5-year, 10-
year, and 15-year follow up results in the 69 patients who
had complete postoperative electrophysiologic studies doc-
umenting cure of their AF and those who were not subjected
to postoperative electrophysiologic studies.31,63,66,67
FINAL COMMENTS
At some time during the past decade, the notion evolved
that a 70% to 80% success rate is satisfactory when per-
forming surgery for AF. Who lowered the bar? We don’t ac-
cept such a success rate for any other type of adult cardiac
surgery, so why should we accept it for AF surgery? A recent
update on 16,309 patients undergoing catheter ablation for
AF of all types reported success rates in that same range,68
so why would a cardiologist refer a patient with AF for sur-
gery if our results are no better than theirs? As with other
types of cardiac surgery, 2 factors will determine whether
AF surgery has a future: (1) outcomes and (2) invasiveness.
Regardless of how ‘‘minimally invasive’’ we can make
a procedure, however, surgery will never become a frontline
option for AF unless we can cure essentially all patients with
a single operation. Of course, that operation must compare
favorably with catheter ablation in terms of invasiveness,
but outcomes will determine our relevance in the foreseeable
future.
We are not in competition with cardiologists for patients
who might undergo stand-alone surgery for primary PAF
or patients who need concomitant surgery for secondary
PAF or CAF. Cardiologists treat primary PAF, and surgeons
already treat secondary PAF and CAF. Thus the future of AF
surgery depends on our ability to develop a stand-alone oper-
ative procedure thatwill offer patientswith primaryCAFavi-
able alternative to the cardiologists’ approach. Despite their
gross ‘‘rounding up’’ of the true success rates for catheter ab-
lation in the update mentioned previously,68 only a few car-
diologists actually attempt to treat primary CAF, because
fortunately most of them are unwilling to create the massive
atrial tissue destruction that is necessary to attain such out-
comes in these patients.69-71 They do, however, have
another option for patients with primary CAF. With the
recent development of percutaneous methods for closing
the left atrial appendage,72,73 cardiologists will likely begin
to treat Primary CAF by electively ablating the His bundle,
inserting a permanent pacemaker, and closing the left atrial
appendage. Not only will this allow all antiarrhythmic
drugs to be discontinued, but closure of the left atrial
appendage will also allow warfarin to be stopped.73 This ap-
proach has the additional advantage of being simple enough
to be performed by all interventional cardiologists, not just
trained electrophysiologists, and we can certainly expect
the pacemaker companies to look favorably on this practice.
It is this procedure that will be our competition for patients
with primary CAF in the future. We will have to develop
a surgical procedure that is at least somewhat comparable1384 The Journal of Thoracic and Cardiovascular Surin invasiveness to catheter ablation, meaning that it will
have to be an endoscopic or robotic off-pump procedure
that avoids general anesthesia, endotracheal intubation, and
postoperative chest tubes. More importantly, it will have to
achieve outcomes comparable to those of the original cut-
and-sew maze III procedure. That may seem like a tall order,
but if it can be accomplished, we should be able to compete
very effectively with a procedure that leaves patients in AF
and requires a permanent pacemaker! If so, the 1.2 million
people in the United States with primary CAF will become
potential surgical patients. If not, AF surgery will continue
to be confined to the relatively few patients with secondary
AF who are already coming to our operating rooms. That
sounds like a challenge worthy of a surgeon’s attention.References
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